Prognostic factor | Peritoneal metastasis | P value | |||
---|---|---|---|---|---|
No | Yes | ||||
N | % | N | % | ||
Age (year) | 56.2 ± 12.6 | 51.4 ± 12.5 | 0.02 | ||
Gender | |||||
Male | 85 | 59.0 | 27 | 45.8 | |
Female | 59 | 41.0 | 32 | 54.2 | 0.084 |
Site of the tumora | |||||
Distal | 52 | 36.1 | 9 | 15.3 | |
Middle | 45 | 31.3 | 33 | 55.9 | |
Proximal | 47 | 32.6 | 17 | 28.8 | 0.002 |
Morphology | |||||
Polypoidal mass | 110 | 76.4 | 38 | 64.4 | |
Thickening | 7 | 4.9 | 14 | 23.7 | |
Ulcer | 27 | 18.8 | 7 | 11.9 | < 0.001 |
T stageb | |||||
T2 | 8 | 11.9 | 1 | 5.0 | |
T3 | 25 | 37.3 | 6 | 30.0 | |
T4 | 31 | 46.3 | 13 | 65.0 | 0.523 |
N stage b | |||||
N0 | 24 | 35.8 | 2 | 10.0 | |
N1 | 14 | 20.9 | 6 | 30.0 | |
N2 | 18 | 26.9 | 5 | 25.0 | |
N3 | 11 | 16.4 | 7 | 35.0 | 0.074 |
Histological type | |||||
Adenocarcinoma NOS | 98 | 68.1 | 29 | 49.2 | |
Mucinous adenocarcinoma | 5 | 3.5 | 3 | 5.1 | |
Signet ring adenocarcinoma | 38 | 26.4 | 23 | 39.0 | |
Undifferentiated carcinoma | 3 | 2.1 | 4 | 6.8 | 0.040 |
Grade | |||||
Grade I | 4 | 2.8 | 1 | 1.7 | |
Grade II | 95 | 66.0 | 20 | 33.9 | |
Grade III | 45 | 31.3 | 38 | 64.4 | < 0.001 |
Neutrophils | |||||
<= 4.17 | 56 | 41.2 | 20 | 34.5 | |
> 4.17 | 80 | 58.8 | 38 | 65.5 | 0.382 |
Lymphocytes | |||||
<= 1.9 | 64 | 47.1 | 37 | 63.8 | |
> 1.9 | 72 | 52.9 | 21 | 36.2 | 0.033 |
NLR | |||||
<= 2.6 | 72 | 53.7 | 26 | 47.3 | |
> 2.6 | 62 | 46.3 | 29 | 52.7 | 0.420 |
Albumin | |||||
<= 3.5 | 68 | 59.6 | 27 | 56.3 | |
> 3.5 | 46 | 40.4 | 21 | 43.8 | 0.688 |
CEA | |||||
<= 5 | 54 | 69.2 | 23 | 57.5 | |
> 5 | 24 | 30.8 | 17 | 42.5 | 0.205 |
CA19-9 | |||||
<= 37 | 53 | 71.6 | 20 | 51.3 | |
> 37 | 21 | 28.4 | 19 | 48.7 | 0.032 |